HI MOBILITY BERHAD DEBUTS ON THE MAIN MARKET AT RM1.27
HI Mobility Berhad debuts on Bursa Malaysia at RM1.27 per share, raising RM115.9 million for fleet expansion, EV infrastructure, and tech upgrades. CEO Lim Chern Chuen reaffirms commitment to innovation and sustainable transit
HI MOBILITY BERHAD UNVEILS IPO PROSPECTUS FOR MAIN MARKET LISTING
HI Mobility Berhad (“HI Mobility”) has launched its IPO prospectus ahead of its 28 March 2025 listing on Bursa Malaysia’s Main Market. The IPO aims to raise RM115.9 million, primarily for fleet expansion, EV charging infrastructure, and technology upgrades.
HI MOBILITY BERHAD INKS UNDERWRITING AGREEMENT, ENROUTE TO MAIN MARKET LISTING
HI Mobility Berhad (“HI Mobility”) has signed a retail underwriting agreement with Maybank Investment Bank ahead of its IPO on Bursa Malaysia’s Main Market. A key player in mass transit, the Group operates cross-border and local bus services under ‘Causeway Link’ and has been integrating electric buses since 2023.
The IPO includes a public issue of 95.0 million new shares and an offer for sale of 35.0 million existing shares. CEO Lim Chern Chuen sees this as a milestone in HI Mobility’s journey toward sustainable, energy-efficient public transport.
TMK CHEMICAL BHD DEBUTS ON THE MAIN MARKET AT RM1.97
TMK Chemical Bhd (“TMK”) has debuted on the Main Market of Bursa Malaysia, opening at RM1.97, a 12.6% premium over its RM1.75 IPO price. The company raised RM385.0 million from 220 million new shares, targeting growth initiatives including plant expansion and acquisitions. Managing director Wong Kin Wah noted the milestone’s significance for TMK’s future. Maybank Investment Bank Berhad is the principal adviser for the IPO.
TMK CHEMICAL BHD UNVEILS IPO PROSPECTUS
TMK Chemical Bhd (“TMK”) has launched its IPO prospectus ahead of its Main Market listing on Bursa Malaysia, scheduled for 12 December 2024. The IPO aims to raise RM385 million through 220 million new shares priced at RM1.75 each, with proceeds earmarked for plant expansion, acquisitions, and debt repayment.
Managing Director Wong Kin Wah emphasized TMK’s evolution over 35 years into a regional leader in inorganic chemicals, driven by innovation and customer trust.
Public subscription closes at 5:00 PM on 29 November 2024, with Maybank Investment Bank Berhad as the principal adviser and sole underwriter.
TMK CHEMICAL BHD INKS RETAIL UNDERWRITING AGREEMENT
TMK Chemical Bhd has officially signed a retail underwriting agreement with Maybank Investment Bank Berhad as it prepares for its IPO on Bursa Malaysia in Q4 2024. The TMK Group operates 15 facilities across the region, providing comprehensive chemical management services.
3REN BERHAD EMBARKS ON A NEW ERA, MAKING DEBUT ON THE ACE MARKET AT RM0.335
3REN Berhad (“3REN”) debuted on the ACE Market of Bursa Malaysia with an opening price of RM0.335, a 19.6% premium over its issue price. Through its IPO, 3REN raised RM30.8 million, primarily allocated for business expansion, R&D, and a new Singapore office.
SUNVIEW’S ASSOCIATE WINSTAR GETS LISTING APPROVAL
Sunview Group Berhad is pleased to announce that Winstar Capital Berhad has received approval for its listing on the ACE Market from Bursa Malaysia Securities Berhad, with an expected debut in Q4 2024.
NORTHEAST DEBUTS ON THE ACE MARKET AT RM0.53
Northeast Group Berhad (“Northeast”), a precision engineering components manufacturer, made its debut on the ACE Market of Bursa Malaysia, with shares opening at RM0.53, a 6.0% premium over its IPO price of RM0.50.
The IPO raised RM84.49 million, with funds allocated for a new factory, CNC machines, and debt repayment. Managing Director Ng Chay Chin emphasized the Group’s focus on expansion, production efficiency, and global growth.
3REN BERHAD LAUNCHES IPO PROSPECTUS
3REN Berhad (“3REN”) launched its IPO prospectus today ahead of its listing on the ACE Market of Bursa Malaysia on 6 November 2024. The IPO aims to raise RM30.8 million through the issuance of 110 million shares at RM0.28 per share, primarily for business expansion, R&D, and setting up new facilities.
